With regard to MYC-dependent cancers, we found a strong SENP6-dependent increase of SUMO2/3 conjugates, revealing that SUMO conjugation is activated either by induction of the SUMO conjugation machinery or by loss of the cellular safeguard deSUMOylase SENP6. The gene discussed is SENP6; the disease is cancer.